2026 Keyword Index

A

  • acute complications, 285
  • advocates, 383
  • aesthetic outcome, 447
  • aesthetic outcomes, 340
  • algorithm, 199
  • antibody-drug conjugates, 240
  • artificial intelligence, 35, 218
  • autologous reconstruction, 285
  • Avelumab, 505
  • axillary lymph node, 358
  • axillary lymph node dissection, 441
  • axillary lymphadenectomy, 61
  • azathioprine, 270

B

C

  • calcifications, 358
  • CD56 marker, 505
  • cell-cycle/mitotic targets, 240
  • central breast cancer, 340
  • CGRA, 374
  • Chest wall perforator flaps, 294, 393
  • China, 373
  • chronic mastitis, 126
  • CK20 positivity, 505
  • classification, 199
  • clinical decision support systems, 35
  • codes, 382
  • Colonic breast metastasis, 102
  • comorbidity, 261
  • complete remission, 417
  • computed tomography, 485
  • contrast enhanced mammogram, 520
  • contrast media, 520
  • core biopsy, 520
  • cost-effectiveness, 87

D

  • De-escalation of surgery to axilla, 19
  • diabetes, 139
  • diagnosis, 231
  • diagnostic accuracy, 35
  • differential, 231
  • digital breast tomosynthesis, 218
  • disparities, 78
  • DNA damage response, 240
  • Doppler ultrasonography, 72
  • Dubai, 261
  • dura mater, 209

E

  • early breast cancer, 19, 328, 407
  • early detection, 147
  • Early stages, 375
  • early-stage, 1, 115
  • endocrine disruptors, 25
  • endoscopic breast surgery, 476
  • Endoscopic mastectomy, 165, 370
  • environmental carcinogens, 25
  • EORTC QLQ-BR23, 426, 494
  • EORTC QLQ-C30, 426, 494
  • extrahepatic gastrointestinal metastasis, 102

F

  • feasibility, 61
  • fistula, 417

G

  • Genetic testing, 377, 380
  • germline, 379
  • Gestational gyganomastia, 98
  • giant fibroadenoma, 226
  • granulomatous, 199
  • Granulomatous mastitis, 307
  • Grisotti flap, 340
  • gross examination, 279
  • guidelines, 328, 377, 385

H

  • handx, 370
  • health literacy, 372
  • heavy metals, 25
  • HER2 negative, 505
  • HER2 protein, 318
  • Herpes zoster, 231
  • high-risk, 380
  • hirudotherapy, 417
  • HMG family, 248
  • hormone receptor-positive, 87
  • HR+/HER2, 384
  • Hypofractionated, 385

I

  • IBC, 382
  • Idiopathic, 199
  • Idiopathic granulomatous mastitis, 126, 270, 417
  • ileocecal metastasis, 102
  • image guided biopsy, 156, 520
  • immediate lymphatic reconstruction, 441
  • immunohistochemistry, 501
  • immunosuppressive therapy, 270
  • immunotherapy, 240
  • implant rupture, 434
  • India, 165
  • inflammatory breast disease, 126
  • inflammatory lesions, 126
  • inframammary fold, 209
  • international, 373
  • international survey, 328
  • intraoperative ultrasound, 279
  • invasive lobular carcinoma, 102

J

  • Jordan, 426
  • juvenile fibroadenoma, 226

K

L

  • lactational mastitis, 98
  • Lead exposure, 25
  • learning curve, 370
  • Lesions of uncertain malignant potential, 190
  • LICAP flap, 455
  • lobular carcinoma breast, 102
  • low-resource setting, 279, 441
  • lumpectomy, 78, 171
  • LYMPHA, 441
  • Lymphedema, 61, 381
  • lymphomas, 466

M

  • machine learning, 35, 218, 307
  • Magee equations (TM), 87
  • magnetic resonance imaging, 44, 156, 328, 350, 434
  • male breast, 501
  • mammaplasty, 72
  • mammography, 92, 106, 218, 372, 520
  • mammoplasty, 226
  • margin assessment, 279
  • mastectomy, 78, 171
  • mastitis, 199
  • merkel cell carcinoma, 505
  • merkel cell carcinoma of the breast, 505
  • mesenchymal tumor, 501
  • metabolic reprogramming, 240
  • metastasis, 386
  • methotrexate, 270
  • mid-treatment, 44
  • minimally invasive breast surgery, 476
  • minimally invasive mastectomy, 370
  • minimally invasive surgery, 165
  • modified radical mastectomy, 494
  • mRNA expression, 248
  • multidisciplinary, 1, 115
  • muscular weakness, 378
  • mutation, 156
  • Myeloid sarcoma, 363
  • myofascial adhesion, 54
  • myofascial dysfunction, 54
  • Myofibroblastoma, 501

N

  • neoadjuvant chemotherapy, 44, 139, 374, 485
  • neoadjuvant therapy, 350
  • neuroendocrine carcinoma of the breast, 505
  • Newly diagnosed, 383
  • nipple, 231
  • nipple-areola complex excision, 340
  • nipple-sparing mastectomy, 165
  • NQMBC, 373
  • nutrition, 372

O

  • oncology, 1
  • Oncoplastic, 376
  • Oncoplastic breast surgery, 294, 340, 455
  • oncoplastic surgery, 226, 393
  • Oncotype Dx, 87
  • outcome, 466
  • overall survival, 171

P

  • partial breast reconstruction, 455
  • pathologic complete response, 44, 350
  • pathology, 115
  • patient reported outcomes, 494
  • perforator flap, 72
  • personalised oncology, 372
  • polytetrafluoroethylene, 209
  • post neoadjuvant systemic therapy, 19
  • postoperative morbidity, 61
  • practice patterns, 328
  • precision oncology, 240
  • predictive models, 35
  • predictive value of tests, 350
  • predictors, 426
  • preoperative staging, 328
  • primary angiosarcoma, 92
  • prognostic markers, 248
  • prospective trial, 66
  • pseudocalcifications, 106
  • Public awareness, 372

Q

R

  • radiation oncology, 115
  • radiation therapy, 511
  • Radiation-induced angiosarcoma, 511
  • radiology, 115
  • radiotherapy, 66, 494
  • randomized controlled trial, 426
  • real-world data, 318
  • reconstruction, 165
  • recurrence, 307, 417
  • reduction mammoplasty, 98
  • relapse, 270
  • research gaps, 382
  • retrospective observational study, 393
  • risk-adapted treatment, 270
  • robotic breast surgery, 476
  • robotic mastectomy, 165, 370

S

  • S-LYMPHA, 441
  • sarcopenia, 139
  • scar tissue, 54
  • screening, 147, 372
  • SDHx, 379
  • second-line breast biopsy, 190
  • secondary malignancy, 511
  • self-injection, 234
  • sentinel lymph node biopsy, 61, 518
  • sentinel lymph nodes, 518
  • skeletal muscle index, 485
  • South Africa, 372, 376, 384, 385
  • specimen mammography, 279
  • spontaneous remission, 417
  • Staging, 384
  • standards, 375
  • STROBE, 494
  • surgery, 115, 190, 386
  • surgical approach, 78
  • Surgical complications, 285
  • surgical de-escalation, 523
  • surgical delay, 374
  • surgical flaps, 72
  • surgical management, 407
  • surgical margins, 340
  • survival, 374, 386
  • survival analysis, 248, 318
  • Survivor, 386
  • survivorship, 372
  • systematic review, 374
  • systemic, 1

T

  • Tattoo, 358
  • test outcomes, 374
  • three-dimensional surface imaging, 447
  • toxicity, 66
  • treatment, 184, 383, 466
  • Treatment cost, 261
  • treatment outcome, 72
  • treatment study, 386
  • trials, 19
  • Triple-negative breast cancer (TNBC), 240
  • tucatinib, 318

U

  • ultra-hypofractionation, 66
  • ultrasonography, 363, 434
  • ultrasound, 407
  • United Arab Emirates, 261
  • upfront surgery, 19
  • upgrade risk, 523

V

  • vacuum-assisted biopsy, 190
  • vacuum-assisted-excision, 190, 523

W

  • webinar, 372
  • Wise-pattern oncoplastic reconstruction, 340
  • workflow, 376

Y